Loading organizations...
§ Private Profile · London, United Kingdom
Medtech startup developing fiber optic sensing technology to improve sensing and imaging in minimally invasive cardiovascular surgery.
Based in London, England, Echopoint Medical is a medical technology enterprise that develops fiber optic sensing technology and custom algorithms to improve imaging during minimally invasive cardiovascular surgical procedures. The company's hardware platform integrates directly into existing surgical tools to assist clinicians in navigating and treating tiny blood vessels in patients suffering from vascular disease. To date, the enterprise has raised a total of £7 million in venture capital, which includes a recent £4.2 million Series A financing round alongside £2.8 million in prior seed funding and grants. This financial backing has been provided by a syndicate of institutional investors and university investment vehicles, prominently featuring recognizable entities such as Parkwalk and the UCL Technology Fund. Echopoint Medical was originally established as a University College London spinout in 2018 by co-founders Adrien Desjardins and Malcolm Finlay.
Echopoint Medical has raised $8.5M across 2 funding rounds.
Echopoint Medical has raised $8.5M in total across 2 funding rounds.
Echopoint Medical has raised $8.5M across 2 funding rounds. Most recently, it raised $5.0M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2024 | $5M Series A | Parkwalk Advisors, David Grimm | ACF Investors, Albion VC, Evening Fund, Gerald Parloiu, Shane Curran, UCL Business | Announced |
| Sep 16, 2019 | $3.5M Venture Round | — | Innovate UK, Neil Cameron, UCL | Announced |
Echopoint Medical Ltd is a London-based medtech company developing the iKOr™ microcatheter system, an advanced diagnostic tool using optical fiber ultrasound sensors to provide cardiologists with real-time physiological insights for coronary conditions.[1][2][4][5] It serves cardiologists in cath labs, addressing imprecise diagnostics in coronary heart disease—particularly the gender gap in cardiovascular care for women—by enabling tailored treatments that improve outcomes without disrupting workflows.[1][2] The company, incorporated in 2018 with under $5M in funding including a £2.8M round from Parkwalk, UCL Technology Fund, and Innovate UK grants, focuses on manufacturing medical instruments and shows steady progress toward commercialization, with accounts current to 2024.[3][4]
Echopoint Medical was incorporated on November 9, 2018, as a private limited company in London, specializing in medical and dental instruments (SIC 32500).[3] Founded by a multidisciplinary team of engineers, clinicians, and entrepreneurs, the idea emerged from the need for better sensing in minimally invasive procedures, leading to optical fiber-based sensors integrated into devices like microcatheters.[2][4][5] Early traction came via a £2.8M funding round to advance the iKOr system and its ultrasound signal platform, marking a pivotal step in development.[4]
Echopoint rides the trend toward precision medtech in cardiology, where detailed physiological data drives personalized treatments amid rising demand for minimally invasive tools.[1][2] Timing aligns with growing evidence for tailored coronary therapies and efforts to address gender disparities in heart disease, amplified by post-pandemic focus on efficient cath lab tech.[1] Market forces like aging populations and innovation in optical sensing favor it, positioning Echopoint to influence cardiovascular ecosystems by enhancing diagnostic accuracy and outcomes globally.[4][5]
Echopoint's next milestones include advancing iKOr toward full regulatory approval and market launch, leveraging recent funding for platform scaling.[3][4] Trends like AI-enhanced diagnostics and expanded women's heart health initiatives will shape its path, potentially amplifying its role in revolutionizing coronary care. As it grows, Echopoint could set new standards in physiological sensing, empowering cardiologists with tools that close care gaps and boost precision from the cath lab outward—echoing its mission to transform diagnostics at the outset.[1][2]
Echopoint Medical has raised $8.5M in total across 2 funding rounds.
Echopoint Medical's investors include Parkwalk Advisors, David Grimm, ACF Investors, Albion VC, Evening Fund, Gerald Parloiu, Shane Curran, UCL Business, Innovate UK, Neil Cameron, UCL.